These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 530924)

  • 1. The treatment and progress of obese insulin independent diabetics.
    Borsey DQ; Fraser DM; Duncan LJ
    Practitioner; 1979 Nov; 223(1337):678-81. PubMed ID: 530924
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
    Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
    Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin in the treatment of obese diabetics.
    Mehrotra TN; Young BA
    Br J Clin Pract; 1967 Feb; 21(2):85-6. PubMed ID: 6037937
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chlorpropamide-metformin in obese diabetics or diabetics with side effects from sulfonylureas. 2-year results].
    Garcia Viveros M; Prado Vega R; Rull JA; Lozano-Castañeda O
    Prensa Med Mex; 1971; 36(7):347-9. PubMed ID: 5096256
    [No Abstract]   [Full Text] [Related]  

  • 5. Metformin in the treatment of obese diabetics.
    Shenfield GM; Bhalla IP; Steel JM; Duncan LJ
    Practitioner; 1977 Nov; 219(1313):745-9. PubMed ID: 594027
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the use of ER 102 in the treatment of diabetes mellitus].
    Selvini A; Brugi A; Emanueli A
    Minerva Med; 1967 Jan; 58(7):189-96. PubMed ID: 6018158
    [No Abstract]   [Full Text] [Related]  

  • 7. The results of diet therapy vs insulin in the management of obese diabetics.
    Flinn LB
    Del Med J; 1978 Jul; 50(7):375-80. PubMed ID: 668958
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of metformin on fibrinogen levels in obese patients with type 2 diabetes.
    Fanghänel G; Silva U; Sanchez-Reyes L; Sisson D; Sotres D; Torres EM
    Rev Invest Clin; 1998; 50(5):389-94. PubMed ID: 9949668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chlorpropamide-metformin in obese diabetic patients or with secondary response failure to sulfonylureas].
    Garcia Viveros M; Lozano Castañeda O; Quibrera Infante R; Rull JA
    Prensa Med Mex; 1969; 34(9):391-6. PubMed ID: 5378265
    [No Abstract]   [Full Text] [Related]  

  • 10. [Double aim in the treatment of diabetes in obese patients: glycemia equilibration, lipid constant normalization. Trial of delayed-action N,N-dimethyl-biguanide].
    Félix H; Freyria J
    Therapeutique; 1970 Jan; 46(1):61-6. PubMed ID: 5444071
    [No Abstract]   [Full Text] [Related]  

  • 11. [The anti-atherosclerotic effect of metformin in the initial phases of diabetes mellitus in adults].
    Baraldi B; Maestri G; Cusimano A; Valenti C; Tiraboschi L; Cocuzza E; Angeli G
    Clin Ter; 1980 Mar; 92(6):657-69. PubMed ID: 7006885
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus.
    Ravipati G; Aronow WS; Ahn C; Sujata K; Saulle LN; Channamsetty V; Weiss MB
    Am J Ther; 2006; 13(5):400-3. PubMed ID: 16988534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus--refractory obesity.
    Br Med J; 1972 Jul; 3(5819):163-5. PubMed ID: 5064737
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum level of retinol-binding protein 4 in obese patients with insulin resistance and in patients with type 2 diabetes treated with metformin].
    Tajtáková M; Semanová Z; Ivancová G; Petrovicová J; Donicová V; Zemberová E
    Vnitr Lek; 2007 Sep; 53(9):960-3. PubMed ID: 18019665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of obese diabetic patients using glucophage retard].
    Munk W
    Z Allgemeinmed; 1975 May; 51(14):681-3. PubMed ID: 1108460
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chlorpropamide-metformin in obese diabetics or diabetics with secondary failure of response to sulfonylureas].
    Gonzalez Millan H; Quibrera Infante R; Rull JA; Lozano Castaneda O
    Prensa Med Mex; 1968; 33(11):465-72. PubMed ID: 5760092
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of phenformin and metformin in the treatment of maturity onset diabetes.
    Cairns SA; Shalet S; Marshall AJ; Hartog M
    Diabete Metab; 1977 Sep; 3(3):183-8. PubMed ID: 913750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biguanides in treatment of obesity. II. Controlled clinical research with placebos, metformin and phenformin in obesity with normal and reduced tolerance to carbohydrates].
    Cucurachi L; Strata A; Zuliani U; Cucurachi P; Dell'Anna A
    Clin Ter; 1968 Nov; 47(3):233-45. PubMed ID: 4911791
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the efficacy of metformin-glibenclamide treatment in overweight non-insulin dependent diabetics].
    Laurenti O; Bravi MC; Faldetta MC; De Mattia G
    Clin Ter; 1992 Mar; 140(3):259-63. PubMed ID: 1568370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary findings on 2 groups of diabetics with regard to platelet aggregation in relation to retinopathy and ultimate relation to antidiabetic therapy].
    Cavaliere R; Giangrandi E; Innocenti M; Parisi R
    Minerva Med; 1978 Jun; 69(28):1923-8. PubMed ID: 662185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.